Compared with other groups, administration of PEG-TECM-NS/OLE markedly reduced the number of Ki67 proliferating tumour cells and increased the number of dUTP nick-end labelling (TUNEL)-positive tumour cells (Fig. 5n). Here, MKI67 is linked to neoplasm.